This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barr, S. D.
Right arrow Articles by Bushman, F. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barr, S. D.
Right arrow Articles by Bushman, F. D.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

 Previous Article  |  Next Article 

Journal of Virology, September 2005, p. 12035-12044, Vol. 79, No. 18
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.18.12035-12044.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Integration Targeting by Avian Sarcoma-Leukosis Virus and Human Immunodeficiency Virus in the Chicken Genome{dagger}

Stephen D. Barr,1 Jeremy Leipzig,1 Paul Shinn,2 Joe R. Ecker,2 and Frederic D. Bushman1*

University of Pennsylvania School of Medicine, Department of Microbiology, 3610 Hamilton Walk, Philadelphia, Pennsylvania,1 Genomic Analysis Laboratory, The Salk Institute, 10010 North Torrey Pines Rd., La Jolla, California 920372

Received 20 April 2005/ Accepted 27 June 2005

We have analyzed the placement of sites of integration of avian sarcoma-leukosis virus (ASLV) and human immunodeficiency virus (HIV) DNA in the draft chicken genome sequence, with the goals of assessing species-specific effects on integration and allowing comparison to the distribution of chicken endogenous retroviruses (ERVs). We infected chicken embryo fibroblasts (CEF) with ASLV or HIV and sequenced 863 junctions between host and viral DNA. The relationship with cellular gene activity was analyzed by transcriptional profiling of uninfected or ASLV-infected CEF cells. ASLV weakly favored integration in active transcription units (TUs), and HIV strongly favored active TUs, trends seen previously for integration in human cells. The ERVs, in contrast, accumulated mostly outside TUs, including ERVs related to ASLV. The minority of ERVs present within TUs were mainly in the antisense orientation; consequently, the viral splicing and polyadenylation signals would not disrupt cellular mRNA synthesis. In contrast, de novo ASLV integration sites within TUs showed no orientation bias. Comparing the distribution of de novo ASLV integration sites to ERVs indicated that purifying selection against gene disruption, and not initial integration targeting, probably determined the ERV distribution. Further analysis indicated that ERVs in humans, mice, and rats showed similar distributions, suggesting purifying selection dictated their distributions as well.


* Corresponding author. Mailing address: University of Pennsylvania School of Medicine, Department of Microbiology, 3610 Hamilton Walk, Philadelphia, PA 19104-6076. Phone: (215) 573-8732. Fax: (215) 573-4856. E-mail: bushman{at}mail.med.upenn.edu.

{dagger} Supplemental material for this article may be found at http://jvi.asm.org/.


Journal of Virology, September 2005, p. 12035-12044, Vol. 79, No. 18
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.18.12035-12044.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Brady, T., Lee, Y. N., Ronen, K., Malani, N., Berry, C. C., Bieniasz, P. D., Bushman, F. D. (2009). Integration target site selection by a resurrected human endogenous retrovirus. Genes Dev. 23: 633-642 [Abstract] [Full Text]  
  • Kim, S., Kim, N., Dong, B., Boren, D., Lee, S. A., Das Gupta, J., Gaughan, C., Klein, E. A., Lee, C., Silverman, R. H., Chow, S. A. (2008). Integration Site Preference of Xenotropic Murine Leukemia Virus-Related Virus, a New Human Retrovirus Associated with Prostate Cancer. J. Virol. 82: 9964-9977 [Abstract] [Full Text]  
  • Shin, S. S., Kim, T. M., Kim, S. Y., Kim, T. W., Seo, H. W., Lee, S. K., Kwon, S. C., Lee, G. S., Kim, H., Lim, J. M., Han, J. Y. (2008). Generation of transgenic quail through germ cell-mediated germline transmission. FASEB J. 22: 2435-2444 [Abstract] [Full Text]  
  • Wang, G. P., Garrigue, A., Ciuffi, A., Ronen, K., Leipzig, J., Berry, C., Lagresle-Peyrou, C., Benjelloun, F., Hacein-Bey-Abina, S., Fischer, A., Cavazzana-Calvo, M., Bushman, F. D. (2008). DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer. Nucleic Acids Res 36: e49-e49 [Abstract] [Full Text]  
  • Faschinger, A., Rouault, F., Sollner, J., Lukas, A., Salmons, B., Gunzburg, W. H., Indik, S. (2008). Mouse Mammary Tumor Virus Integration Site Selection in Human and Mouse Genomes. J. Virol. 82: 1360-1367 [Abstract] [Full Text]  
  • Yang, F., Xian, R. R., Li, Y., Polony, T. S., Beemon, K. L. (2007). Telomerase reverse transcriptase expression elevated by avian leukosis virus integration in B cell lymphomas. Proc. Natl. Acad. Sci. USA 104: 18952-18957 [Abstract] [Full Text]  
  • Katzourakis, A., Pereira, V., Tristem, M. (2007). Effects of Recombination Rate on Human Endogenous Retrovirus Fixation and Persistence. J. Virol. 81: 10712-10717 [Abstract] [Full Text]  
  • Wang, G. P., Ciuffi, A., Leipzig, J., Berry, C. C., Bushman, F. D. (2007). HIV integration site selection: Analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Genome Res 17: 1186-1194 [Abstract] [Full Text]  
  • Cherepanov, P. (2007). LEDGF/p75 interacts with divergent lentiviral integrases and modulates their enzymatic activity in vitro. Nucleic Acids Res 35: 113-124 [Abstract] [Full Text]  
  • Kim, S., Kim, Y., Liang, T., Sinsheimer, J. S., Chow, S. A. (2006). A High-Throughput Method for Cloning and Sequencing Human Immunodeficiency Virus Type 1 Integration Sites. J. Virol. 80: 11313-11321 [Abstract] [Full Text]  
  • MacNeil, A., Sankale, J.-L., Meloni, S. T., Sarr, A. D., Mboup, S., Kanki, P. (2006). Genomic Sites of Human Immunodeficiency Virus Type 2 (HIV-2) Integration: Similarities to HIV-1 In Vitro and Possible Differences In Vivo.. J. Virol. 80: 7316-7321 [Abstract] [Full Text]